The 2026 proxy season begins against a backdrop of declining proposal volume, rising exclusion requests, and reduced SEC staff mediation, according to a new report by The Conference Board.
As with so many core functions of public health, the future success of vaccine promotion research depends on the support of every institution: government, universities, and industry alike.